Well, I guess @johndprent's target of $3 will happen when you announced this "Ph2" clinical trial is starting???? The market has likely factored in positive clinical trial updates for Ph1 into the MC right now given RC220 is essentially RC110 which has already been approved to use in France in 1990, we will know in at least 10 months time when you do an interim data cut and announced the data.
RAC Price at posting:
$1.14 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)